MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, IDYA has $1,030,348K in assets. $93,081K in debts. $157,522K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1073.73%
Quick Ratio
1073.73%
Cash Ratio
242.97%
Debt to Asset Ratio
9.03%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term marketable securities
    • Long-term marketable securities
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Long-term operating lease liabil...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
157,522 112,825 298,927 114,645
Short-term marketable securities
513,679 526,563 487,967 555,093
Prepaid expenses and other current assets
18,346 21,366 15,761 15,864
Contract assets
6,560 5,973 --
Total current assets
696,107 666,727 802,655 685,602
Restricted cash
1,281 1,015 805 805
Long-term marketable securities
301,713 410,297 349,960 322,131
Total property and equipment
23,579 22,473 21,862 -
Less accumulated depreciation and amortization
14,945 14,256 13,690 -
Property and equipment, net
8,634 8,217 8,172 8,819
Right-of-use assets
22,613 23,068 23,544 23,913
Total assets
1,030,348 1,109,324 1,185,136 1,041,270
Accounts payable
20,736 17,584 18,433 17,270
Accrued liabilities
43,745 40,892 45,258 37,750
Contract liabilities, current
--490 -
Operating lease liabilities, current
350 339 328 318
Total current liabilities
64,831 58,815 64,509 55,338
Long-term contract liabilities
--1,676 -
Long-term operating lease liabilities
28,250 27,575 26,917 26,279
Total liabilities
93,081 86,390 93,102 81,617
Common stock, 0.0001 par value, 300,000,000 shares authorized as of march 31, 2026 and december 31, 2025 87,856,154 and 87,796,561 shares issued and outstanding as of march 31, 2026 and december 31, 2025
9 9 9 9
Additional paid-in capital
1,772,830 1,757,197 1,743,239 1,730,633
Accumulated other comprehensive (loss) income
-494 2,267 2,052 1,521
Accumulated deficit
-835,078 -736,539 -653,266 -772,510
Total stockholders equity
937,267 1,022,934 1,092,034 959,653
Total liabilities and stockholders equity
1,030,348 1,109,324 1,185,136 1,041,270
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term marketablesecurities$513,679K Cash and cashequivalents$157,522K Prepaid expenses andother current assets$18,346K Contract assets$6,560K Total property andequipment$23,579K Total current assets$696,107K Long-term marketablesecurities$301,713K Right-of-use assets$22,613K Property and equipment,net$8,634K Restricted cash$1,281K Less accumulateddepreciation and...$14,945K Total assets$1,030,348K Total liabilities andstockholders equity$1,030,348K Total stockholdersequity$937,267K Total liabilities$93,081K Accumulated deficit-$835,078K Accumulated othercomprehensive (loss) income-$494K Additional paid-in capital$1,772,830K Total currentliabilities$64,831K Long-term operating leaseliabilities$28,250K Common stock, 0.0001par value,...$9K Accrued liabilities$43,745K Accounts payable$20,736K Operating leaseliabilities, current$350K

IDEAYA Biosciences, Inc. (IDYA)

IDEAYA Biosciences, Inc. (IDYA)